2004 Quarterly Earnings Reports
Biopharmaceuticals Sector Companies
Updated 4/23/03
Current publicly reported financial results (in $millions) for genomics-based companies. Please note that all figures may reflect non-recurring charges, credits, gains or losses. Company fiscal years may not run according to the calendar year. Earnings will be updated as Network Science receives the data.
| Q1 | Q2 | Q3 | Q4 | YTD | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | |
| Alkermes | $16.10 | ($24.70) | $11.50 | ($36.10) | $27.60 | ($60.80) | ||||
| Amylin (AMLN) | $6.70 | ($37.30) | $7.60 | ($39.40) | $14.30 | ($76.70) | ||||
| Antigenics (AGEN) | $0.50 | ($17.20) | $0.20 | ($3.10) | $0.70 | ($20.30) | ||||
| Ariad (ARAD) | $0.20 | ($6.20) | $0.19 | ($9.20) | $0.39 | ($15.40) | ||||
| Biocryst (BCRX) | $0.20 | ($5.50) | $0.22 | ($5.06) | $0.42 | ($10.56) | ||||
| Cellegy Pharma (CLGY) | $0.34 | ($3.10) | $0.43 | ($2.71) | $0.77 | ($5.81) | ||||
| Cephalon (CEPH) | $214.98 | $21.70 | $239.50 | ($6.85) | $454.48 | $14.85 | ||||
| Cubist (CBST) | $8.50 | ($23.20) | $14.70 | ($17.87) | $23.20 | ($41.07) | ||||
| CV Therapeutics (CVTX) | $2.90 | ($31.30) | $4.30 | ($37.23) | $7.20 | ($68.53) | ||||
| Exelixis (EXEL) | $11.90 | ($28.80) | $12.60 | ($29.30) | $24.50 | ($58.10) | ||||
| Gilead (GILD) | $309.10 | $114.40 | $319.72 | $111.46 | $628.82 | $225.86 | ||||
| Guilford (GLFD) | $8.90 | ($18.10) | $11.15 | ($21.27) | $20.05 | ($39.37) | ||||
| Nektar Therapeutics (NKTR) | $25.83 | ($40.00) | $28.53 | ($22.16) | $54.36 | ($62.16) | ||||
| Indevus (IPIC) | $0.88 | ($11.37) | $0.88 | ($11.37) | ||||||
| Isis Pharmaceutical (ISIP) | $12.30 | ($26.31) | $9.84 | ($25.95) | $22.14 | ($52.26) | ||||
| Kosan Biosciences (KOSN) | $6.40 | ($4.13) | $5.90 | ($5.20) | $12.30 | ($9.33) | ||||
| La Jolla Pharmaceutical (LJPC) | $0.00 | ($8.38) | $0.00 | ($8.40) | $0.00 | ($16.78) | ||||
| Ligand (LGND) | $36.61 | ($13.14) | $40.46 | ($14.22) | $77.07 | ($27.36) | ||||
| MGI Pharmaceuticals (MOGN) | $26.83 | ($3.15) | $47.94 | $8.55 | $74.77 | $5.40 | ||||
| Neurocrine Bioscience (NBIX) | $16.94 | ($12.38) | $15.05 | ($11.13) | $31.99 | ($23.51) | ||||
| Neurogen (NRGN) | $3.15 | ($7.06) | $6.09 | ($4.18) | $9.24 | ($11.24) | ||||
| NPS Pharmaceuticals (NPSP) | $12.01 | ($35.65) | $0.44 | ($41.38) | $12.45 | ($77.03) | ||||
| OSI Pharmaceuticals (OSIP) | $7.22 | ($49.70) | $11.17 | ($47.35) | $18.39 | ($97.05) | ||||
| Progenics Pharma (PGNX) | $1.75 | ($10.22) | $2.17 | ($10.88) | $3.92 | ($21.10) | ||||
| Encysive Pharmaceuticals (ENCY) | $2.84 | ($11.12) | $3.39 | ($12.31) | $6.23 | ($23.43) | ||||
| Trimeris (TRMS) | $1.33 | ($9.88) | $1.64 | ($16.22) | $2.97 | ($26.10) | ||||
| Tularik (TLRK) | Purchased by Amgen Q2/2004 | $10.88 | ($23.76) | |||||||
| Vertex (VRTX) | $17.51 | ($40.44) | $18.54 | ($44.27) | $36.05 | ($84.71) | ||||
| TOTALS | $762.80 | ($365.99) | $813.27 | ($351.73) | $0.00 | $0.00 | $0.00 | $0.00 | $1,576.07 | ($717.72) |
